Skip to main content

What the FDA labels say about taking them together

Caffeine and pentoxifylline

Pentoxifylline's FDA label of May 15, 2026 names caffeine in its contraindications section; the caffeine labels PlainMeds reads (2) do not name pentoxifylline. The pentoxifylline label: “… previously exhibited intolerance to this product or methylxanthines such as caffeine, theophylline, and theobromine.”

Check it at the source: the caffeine FDA label on DailyMed (effective July 29, 2026, Sagent Pharmaceuticals); the pentoxifylline FDA label on DailyMed (effective May 15, 2026, Rising Pharma Holdings, Inc.).

What does the caffeine label say about pentoxifylline?

Caffeine's label (effective July 29, 2026) and its 1 other brand-application label do not name pentoxifylline in these sections. A label lists what its studies and reports found; it is not a complete list.

Source: FDA drug label (caffeine citrate), Sagent Pharmaceuticals, effective July 29, 2026 (SPL set 5f38c395-0093-4afd-89ec-f96e5dc0934a), via openFDA; the full label on DailyMed

What does the pentoxifylline label say about caffeine?

Pentoxifylline label, contraindications

CONTRAINDICATIONS Pentoxifylline extended-release tablets should not be used in patients with recent cerebral and/or retinal hemorrhage or in patients who have previously exhibited intolerance to this product or methylxanthines such as caffeine, theophylline, and theobromine.

Source: FDA drug label (Pentoxifylline), Rising Pharma Holdings, Inc., effective May 15, 2026 (SPL set cd840a2c-2a0e-4b2b-84ff-a0406bb6fa37), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

7Caffeine generic labelers
6Pentoxifylline generic labelers
CaffeinePentoxifylline
Labeled forn/an/a
Boxed warningNoNo
Pharmacy cost (NADAC)$0.083 per tablet 200 mg tablet$0.227 per tablet 400 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?